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Summary. The first human monoclonal islet cell antibodies of 
the IgG class (MICA 1-6) obtained from an individual with 
Type 1 (insulin-dependent) diabetes mellitus were cytoplas- 
mic islet cell antibodies selected by the indirect immunofluo- 
rescence test on pancreas sections. Surprisingly, they all rec- 
ognized the 64 kDa autoantigen glutamate decarboxylase. In 
this study we investigated which typical features of cytoplas- 
mic islet cell antibodies are represented by these monoclo- 
nals. We show by double immunofluorescence testing that 
MICA 1-6 stain pancreatic beta cells which is in agreement 
with the beta-cell specific expression of glutamate decarbox- 
ylase. In contrast an islet-reactive IgM monoclonal ntibody 
obtained from a pre-diabetic ndividual stained all islet cells 
but lacked the tissue specificity of MICA 1-6 and must here- 
fore be considered as a polyreactive IgM-antibody. We fur- 
ther demonstrate that MICA 1~5 revealed typical features of 
epitope sensitivity to biochemical treatment of the target 
tissue which has been demonstrated forislet cell antibodies, 
and which has been used to argue for a lipid rather than a pro- 
tein nature of target antigens. Our results provide direct evi- 
dence that the epitopes recognized by the MICA are de- 
stroyed by methanol/chloroform t eatment but reveal a high 
stability to Pronase digestion compared to proinsulin epi- 
topes. Conformational protein epitopes in glutamate decar- 
boxylase therefore show a sensitivity to biochemical treat- 
ment of sections uch as ganglioside pitopes. MICA 1-6 
share typical features of islet cell and 64 kDa antibodies and 
reveal that glutamate decarboxylase-reactive isletcell anti- 
bodies represent a subgroup of islet cell antibodies present in 
islet cell antibody-positive sera. 
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The humoral autoimmune r sponse to islet specific anti- 
gens in Type 1 (insulin-dependent) diabetes mellitus com- 
prises a variety of islet-specific autoantibodies circulating 
in the serum of affected individuals. Most target mole- 
cules of the autoimmune r sponse to islets were unknown 
for a long time. Therefore the variant islet cell autoanti- 
bodies were classified according to the method by which 
they were detected. Cytoplasmic islet cell antibodies 
(ICA) have been defined by a cytoplasmic staining pat- 
tern of all islet cells in histochemical tests [1,2] and 64 kDa 
antibodies were defined by immunoprecipitation experi- 
ments on in vitro labelled islet cells [3]. Whereas 64 kDa 
antibodies were shown to recognize the beta-cell specific 
enzyme protein glutamate decarboxylase (GAD) [4] ICA 
have been suggested to recognize gangliosides and not 
proteins [5, 6]. Evidence supporting this claim included 
the similarity in biochemical properties of antigens recog- 
nized by anti-ganglioside monoclonal ntibodies with that 
of ICA-positive sera [5], and the observation that ICA 
binding to islet cells is inhibited by glycolipid extracts from 
human pancreas [6]. Our group recently isolated the first 
human monoclonal ICA of the lgG-class (MICA 1-6) 
derived from a patient with newly-diagnosed Type 1 
diabetes [7]. MICA 1-6, which represent five different cir- 
culating primary B-lymphocyte clones from blood [7, 8], 
were selected by the histochemical ICA test and surpris- 
ingly recognized GAD as a target antigen. In addition, 
blocking studies with ICA-positive sera provided clear 
evidence that GAD reactivity of ICA was not limited to 
the single individual from whom the MICA were derived 
[7]. Our data were controversial tothe suggested ganglio- 
side nature of target antigens of ICA [5, 6]. 
In this study we, therefore, addressed the question 
which of the typical features of ICA or 64 kDa antibodies 
are represented by MICA 1-6. We analysed the reactivity 
of the MICA within the islet by double immunofluores- 
cence staining with anti-hormone-specific antibodies and 
compared their tissue specificity with that of FAE7, a new 
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Table 1, Reactivity of MICA 14~ and FAE7 with various human tis- 
sues and islets of different mammalian species 
Human MICA FAE7 Islet MICA FAE7 
tissue a 1-6 cells b 1-6 
Pancreatic 
Islets + + Human + + 
Thyroid - + Rat + - 
Adrenal cortex - - Pig + - 
Adrenal medulla - - Cow + - 
Pituitary - + Monkey + - 
Stomach - - 
Intestine - - 
"Reactivity assessed by peroxidase conjugated pre-formed immune 
complexes. 
b Reactivity assessed by indirect immunofluorescence staining. 
MICA, Human monoclonal IgG-islet cell antibody. 
FAE 7, Human monoclonal islet cell antibody of the IgM-class 
human monoc lonal  ICA  of the IgM-class which we 
der ived from a pre-diabet ic  individual.  We further ana- 
lysed whether  the MICA epitopes in GAD show the typi- 
cal sensitivity of ICA  epitopes reported previously for a 
panel  of ICA-pos i t ive  sera and for anti -gangl ioside anti- 
bodies [5]. Complete ly  dif ferent b iochemical  propert ies  
between GAD and antigens recognized by ICA  from sera 
would suggest hat GAD-react ive  ICA  are a minor  sub- 
group of ICA,  not re levant for the histochemical  staining 
pattern obta ined with ICA-pos i t ive sera from patients 
with Type 1 diabetes. 
Subjects and methods 
Generation of the human monoclonal IgM-ICA FAE7. Blood was 
obtained after informed consent from an ICA-posifive pre-diabetic 
individual who acquired Type 1 diabetes 1year after blood dona- 
tion. B lymphocytes were immortalized by Epstein-Barr virus infec- 
tion as described [9] and supernatants of the cultured cells were 
screened for ICA after 3-4 weeks by the classic indirect immuno- 
fluorescence t st using fiuorescein isothiocyanate (FITC)-labelled 
goat anti-human IgG and IgM antibodies (Dianova, Hamburg, Ger- 
many) [10]. Single cell cloning and stabilisation of the monoclonal 
line was performed as described for the MICA [7]. 
Immunohistochemical characterization. Species specificity and 
cross-reactivity of the monoclonal ntibodies with different human 
tissues was assessed on cryostat sections using either preformed 
complexes of the individual MICA with peroxidase conjugated anti- 
human Ig antibodies [11] or indirect immunofluorescence testing 
[10]. Double immunofluorescence staining was performed by incu- 
bating a mouse monoclonal nti-proinsulin specific antibody (Novo, 
Bagsvaerd, Denmark) diluted 1:5 in supernatant of the different 
MICA on cryostat sections of human pancreas (1 h, 20~ After 
washing in phosphate buffered saline (PB S) (30 rain) the presence of 
antibodies was assessed by FITC-conjugated goat anti-human IgG 
(preabsorbed with mouse serum proteins, Dianova) and rhodamine- 
conjugated goat anti-mouse IgG (preabsorbed with human serum 
proteins, Dianova) diluted 1:30 in PBS (60 rain, 20~ For gluca- 
gon- or somatostatin-specific staining a rabbit anti-glucagon anti- 
body or rabbit anti-somatostatin antibody (Dako, Glostrup, Den- 
mark) and donkey anti-rabbit conjugate (Dianova) were used. 
Pre-treatment of pancreas sections. Cryostat sections of human pan- 
creas from a donor with blood group 0 were processed as described 
[5]. Sections were fixed in acetone (5 rain, 20~ or incubated in 
methanol/chloroform (1:2) (5 min, 20 ~ or, after acetone fixation, 
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washed for 10 min in PBS and incubated with Pronase 0.1 mg/ml in 
PBS (Boehringer, Mannheim, Mannheim, Germany) for 10 rain at 
20~ or with neuraminidase 0.5 U/ml in 50 mmol/1 sodium citrate 
pH 5.5 (Boehringer) for 60 rain at 37 ~ A mouse monoclonal nti- 
human proinsulin antibody (1:10 in PBS; Novo) was used to op- 
timize the duration of the Pronase incubation step. The monoclonal 
antibody A2B5, recognizing a ganglioside antigen in islets [12] was 
used as a control in the neuraminidase incubation step. After pre- 
treatment sections were washed for 15 rain in PBS and staining of the 
antibodies was assessed by the indirect immunofluorescence test. 
Immunoblotting. GAD was purified from the cytosolic fraction of 
pig brain homogenates (10% weight/volume in 20 mmol/l KHzPO4 
pH 7.4, 1 retool/1 phenyl-methyl-sulphonyl-fluoride, i mmol/1 
amino-ethyl-isothiouronium-bromide, 0.02 r tool/1 pyridoxal phos- 
phate). The 33.000 x g supernatant was purified by gelfiltration on a 
Sepharose Q column and fractions with GAD enzyme activity were 
pooled and spotted on nitrocellulose membranes (30 btl/slot of dilu- 
tions 1:10, 1:100 and 1:500) (Hybond; Amersham, Amersham, 
Bucks., UK). Part of the blots were incubated in methanol/chloro- 
form (1:2) for 5 rain (20 ~ or in Pronase (0.1 mg/m110 rain, 20 ~ 
After washing the nitrocellulose membranes were immunostained 
with supernatant of MICA 4 (2 gg/ml), a pool ofafl MICA (2 [tg/ml), 
an irrelevant human monoclonal antibody (2 gg/ml), or the GAD 
65-specific rabbit antiserum 1267 (donated by J.Peterson, Copen- 
hagen, Denmark). Reactivity was detected in an enhanced chemi- 
luminescence assay (Amersham) on Kodak XO Mat film. Mem- 
branes were then washed in PBS and stained with Coomassie bril- 
liant blue. 
Results 
Immunohistochemical haracterization. FAE7,  a human 
monoclonal  ICA  of the IgM class was der ived from a pre- 
diabetic individual  using the above-ment ioned methods.  
React iv i ty of FAE7 and MICA 1-6 was analysed on dif- 
ferent human organs and on pancreas ections of different 
mammal ian  species. In contrast o the MICA,  FAE7 was 
not restr icted to islet cells and did not cross-react with 
pancreas ections of the other mammal ian  species tested. 
Therefore,  only MICA 1-6 exhibited a reactivity typical 
for ICA  (Table 1). 
Cell staining within islets. As judged by double immuno-  
f luorescence staining of the monoc lonal  ant ibodies and 
ant i -hormone specific ant ibodies the MICA showed a 
beta-cel l  restr icted staining pat tern  in many islets which 
over lapped almost complete ly  with that of the anti-pro- 
insulin antibody. However,  some single cells lying at the 
per iphery of some islets, which were negative with the 
proinsul in ant ibody were weakly stained by the MICA,  
especial ly when a poo led supernatant  of M ICA 1-6 was 
appl ied (Fig. 1a-c) .  Cells posit ive for anti -glucagon or 
ant i -somatostat in a t ibodies were negative for the MICA 
when judged within the same section (F ig . ld ,  e and 
results not shown). FAE7,  in contrast, reacted with all cells 
of the islet and in addit ion with single cells of the exocrine 
pancreas as well as with pancreat ic  ducts (Fig. 1 f). 
Biochemical stability of the antigenic epitopes of MICA 1- 
6. We compared  the biochemical  stabil ity of the MICA 
epitopes with that of epi topes recognized by ICA  from 
serum. MICA 3 and MICA 4 were selected because they 
were shown to recognize distinct epi topes in GAD which 
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]pig.l(a-0. Double-fluorochrome immunofluorescence staining of 
a pool of MICA 1-6 and a mouse monoclonal proinsulin-specific 
antibody within the same section f human pancreas ( -e). MICA 1- 
6 were detected with FITC-conjugated anti-human IgG (a) and the 
anti-proinsulin antibody with rhodamine-conjngated anti-mouse 
IgG (b). Double exposure photography of picture a and b is shown 
in c. The yellow colour in c is given by the superimposed green and 
red colour in beta cells. Note that, in addition, there are some green- 
coloured cells visible at the periphery of the islets (indicated by the 
arrow) which are weakly stained by the MICA 1~5, but are negative 
for proinsulin. An islet double stained with MICA 1~5 (green in d) 
and an anti-glucagon-cell specific antibody (red in e) indicates glu- 
cagon-positive c lls negative for the MICA (compare arrows in 
d and e). FAE7 gives a whole islet cell staining pattern in islets (f). 
Scale bar corresponds to100 gm in a, b, e, and f and to 62 gm in 
d and e 
are both common for sera from patients with Type 1 
diabetes [8]. The anti-proinsulin specific monoclonal anti- 
body and the monoclonal antibody A2B5 were included 
as examples of anti-protein and anti-ganglioside specific 
monoclonal antibodies, respectively. Binding of the ICA- 
positive serum and of MICA 3 and MICA 4 was not af- 
fected by treatment of the sections with acetone or Pro- 
nase. However, reactivity with islets was completely abol- 
ished when sections were pre-treated with methanol/chlo- 
roform. Neuraminidase treatment of the tissue optimized 
to ablate binding of the anti-ganglioside antibody A2B5 
decreased the staining of ICA-positive serum and of 
MICA 3 and 4. This reduction of binding, however, was 
non-specific since the same result was achieved when the 
sections were pre-incubated with the control buffer alone 
(50 retool/1 sodium citrate, 37~ pH 5.5). In contrast, 
A2B5 staining was not affected by the buffer control incu- 
bation (Table 2). The biochemical stability of the epitopes 
recognized by MICA 3 and 4 was in line with the bio- 
chemical stability of the epitopes recognized by ICA from 
serum. Except for neuraminidase treatment, MICA 3 and 
4 behaved similarly to the anti-ganglioside antibody 
A2B5. Despite recognizing protein epitopes, MICA 3 and 
4 behaved ifferently from the anti-proinsulin antibody. 
GAD was less sensitive to Pronase than proinsulin. To test 
whether GAD is insensitive to Pronase digestion, various 
concentrations and incubation times of Pronase were ap- 
plied on tissue sections. Titration studies revealed arapid 
degradation of proinsulin by 0.1 mg/ml Pronase in 10- 
15 rain, whereas GAD epitopes recognized by the MICA 
remained stable during that time. A 1-h incubation with 
this Pronase concentration was necessary to degrade pi- 
topes recognized by the MICA (Fig. 2). Alternatively a 10- 
fold increase in Pronase concentration degraded the 
MICA epitopes within 15 min and proinsulin epitopes 
within 2 rain. GAD localized in the tissue, therefore, was 
much less sensitive to unspecific proteolysis by Pronase 
than proinsulin, but was not completely stable. 
Methanol~chloroform treatment destroyed the MICA epi- 
topes. We investigated whether the conformational GAD 
epitopes recognized by MICA 3 and MICA 4 were de- 
stroyed by incubation with methanol/chloroform or
whether elution of GAD from the tissue contributed tothe 
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Table 2. Sensitivity of islet cell epitopes to treatment with fixatives 
and enzymes: evaluation of islet cell staining on pre-treated sections 
Treatment of 
sections 
Immunostaining with a 
MICA MICA ICA- Anti- A2B5 
3 4 positive pro- 
serum insulin 
Untreated + + + + + + + + 
Acetone + + + + + + + + 
Methanol/ - - - + + - 
Chloroform 
Pronase + + + + - + + 
Neuraminidase - ( + ) + + + - 
Control buffer b - ( + ) + + + + + 
a Staining was performed with the indirect immunofiuorescence test 
on cryostat sections of human pancreas. 
b Buffer control incubation of the neuraminidase experiment: 
50 mmol/1 sodium citrate buffer pH 5.5 for 1 h at 37 ~ 
MICA, Human monoclonal IgG-islet cell antibody. ICA, cytoplas- 
mic islet cell antibody. 
Semiquantitativeevaluation of staining: + + very strong; + strong, 
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Fig.2. Sensitivity of proinsulin and glutamate decarboxylase epi- 
topes to Pronase digestion of the tissue section was assessed. Cryo- 
star sections of human pancreas were incubated with Pronase 
(0.1 mg/ml) and after washing an indirect immunofluorescence test 
was performed on pre-treated sections. The titre of a monoclonal 
anti-human proinsulin antibody ( 9 and of a pool of the human 
monoclonal islet cell IgG antibodies MICA 3 and 4 ([]) was as- 
sessed in relation with the time of Pronase digestion of the tissue. 
Antibody titres were not affected by the buffer control incubations 
without Pronase (not shown) 
lack of reactivity after methanol /ch loroform treatment.  
GAD puri f ied from pig bra in  was immobi l i zed on nitrocel-  
lulose and an immunob lot t ing  assaywasper formed.  Part  of 
the blots were pre- t reated with methanol /ch loroform or 
Pronase. GAD pre- t reated with methanol /ch loroform was 
no longer ecognized by MICA 3 and 4, whereas untreated 
or Pronase- t reated GAD was still reactive (Fig. 3). An  ir- 
re levant human monoc lonal  ant ibody of the IgG class did 
not react with any of the slots (not shown). To exclude that 
GAD was not e luted from the nitrocel lulose membrane 
during methanol /ch loroform treatment,  paral le l  blots 
were stained with a polyclonal  serum (1267) raised against 
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Fig.3. Immunoblotting of GAD purified from pig brain. GAD 
(1 mg/ml) was spotted on nitrocellulose atdilutions 1 : 10, 1:100 and 
1:500 (top to bottom) and blots left untreated or incubated with 
methanol/chloroform (5 min, 20~ or Pronase (0.1 mg/ml, 10 min, 
20 ~ After washing blots were immunostained byMICA 4 or a 
polyclonal serum raised against alinear epitope in GAD (1267). An 
enhanced chemiluminescence assay was used to detect he peroxi- 
dase staining on an X-ray film 
a l inear epi tope in GAD.  An  identical  staining intensity 
with methanol /ch loroform-t reated an  untreated GAD 
blots was observed confirming that no elut ion of GAD oc- 
curred. Therefore,  the conformat ional  epitopes recog- 
nized by MICA 3 and 4 must have been destroyed by meth- 
anol /chloroform t reatment  whereas the l inear 1267 epi- 
tope in GAD remained unaffected. 
Discussion 
Human monoc lonal  ant ibodies are an invaluable tool with 
which to study the nature of the humoral  immune re- 
sponse associated with pancreat ic  beta-cel l  destruct ion 
and deve lopment  of Type 1 diabetes. We recent ly ob- 
ta ined the first human monoc lonal  ICA  of the IgG-class 
(M ICA 1~5) der ived from a pat ient  with Type 1 diabetes. 
M ICA 1-6, selected by the classic ICA  test of indirect im- 
munof luorescence all recognized the Type 1 diabetes pe- 
cific 64 kDa autoant igen GAD [7]. The epitopes recog- 
nized by the MICA were mult ip le and common for ICA  
from serum [7, 8]. We here asked the quest ion whether  the 
islet-reactive IgG monoclonals  M ICA 1-6 demonstrate  
all typical features of ICA.  We further invest igated 
whether  FAE7,  a new human monoc lonal  IgM- ICA iso- 
lated from a pre-d iabet ic  ndividual fits in this panel  of dis- 
ease-re lated ICA.  
FAE7 was der ived from b lood obta ined 1 year  before 
onset of Type 1 diabetes, but the ant ibody did not repre- 
sent the typical  features known for ICA-pos i t ive sera. 
Due to its cross-reactivity with human pitui tary cells, thy- 
roid, exocrine pancreat ic  epithel ia, and pancreas ducts, 
FAE7 must be considered as a polyreact ive IgM ant ibody 
like the previous is let-reactive human monoclonal  IgM- 
ant ibodies der ived from patients with Type 1 d iabetes 
[13]. Such polyreact ive IgM-ant ibodies  also occur in nor- 
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mal individuals unrelated to autoimmune diseases [14]. 
Therefore, FAE7 can give no hints on ICA-reactive tar- 
gets during earlier stages of beta-cell destruction i  Type 1 
diabetes. 
Although MICA 1-6 were isolated using the conven- 
tional test for detection of ICA, they demonstrate all the 
known features of GAD antibodies. Beside the precipita- 
tion of a 64 kDa protein from islets and the immunotrap- 
ping of GAD-enzyme activity from brain extracts hown 
previously [7] MICA 1-6 revealed here a predominantly 
beta-cell specific staining pattern in islets which is consist- 
ent with the beta-cell specific expression of GAD [15, 16]. 
In some islets, a few single cells lying in the periphery were 
negative for proinsulin, but were weakly stained by the 
MICA. As glucagon or somatostatin staining did not over- 
lap with the MICA staining, these single cells may be 
identical with the GAD-containing neural cells identified 
recently by Sorenson et al. [17]. These neurons were re- 
ported to be localized in the islet mantle and to extend 
nerve cell processes into the islet. We did not, however, 
test the PP-cell population and cannot exclude that PP 
cells contribute to this staining pattern. 
Only some features typical for ICA were observed for 
the MICA. Whereas the specificity for islet cells and the 
cross-reactivity with islets of different mammalian species 
was typical for ICA, M ICA 1-6 did not show the whole islet 
cell staining pattern reported for many ICA-positive sera 
[2]. Beta-cell specific GAD-reactive ICA, therefore, exist 
in at least some ICA-positive sera. Since many sera from 
newly-diagnosed patients with Type 1 diabetes are positive 
for both ICA and 64 kDa antibodies [3,18], GAD-reactive 
ICA may be very commonin ICA-positive sera. 
Nayak and co-workers [5] have suggested that the islet 
antigen responsible for the ICA staining is a monosialogan- 
glioside. When we analysed the biochemical properties of 
the MICA 3 and MICA 4 epitopes in GAD they revealed 
the same sensitivity to chemical pre-treatment of the tissue 
as epitopes recognized by ICA from serum. In addition, the 
stability of the MICA epitopes, except for the neuramini- 
dase sensitivity, was identical to the anti-ganglioside anti- 
body A2B5 and to the panel of ICA positive sera analysed 
by Nayak and colleagues [5]. The anti-protein control anti- 
body directed to proinsulin behaved ifferently. We were 
able to show that GAD was very stable to Pronase digestion 
of tissue sections. Using GAD immobilized on nitrocellu- 
lose membranes we provided clear evidence that the con- 
formational M ICA epitopes in GAD were destroyed by 
treatment with methanol/chloroform. No elution of GAD 
from nitrocellulose membranes due to methanol/chloro- 
form treatment was evident. However, it cannot be ex- 
cluded that under normal conditions in the tissue sections 
elution of GAD may occur as an additional effect of meth- 
anol/chloroform treatment beside epitope destruction. 
Together our data demonstrate that conformational 
protein epitopes can share sensitivity to chemical pre- 
treatment of the target tissue with ganglioside pitopes. 
Therefore, chemical pre-treatment of the tissue used in 
the past was not suitable to characterize the chemical na- 
ture of target antigens recognized by ICA. The IgG mono- 
clonal antibodies MICA 1-6 share features of both ICA 
and 64 kDa antibodies and must be considered as beta- 
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cell specific GAD-reactive ICA. These data together with 
data from others [19, 20] strongly suggest aheterogeneous 
composition of ICA in ICA-positive sera from patients 
with Type 1 diabetes. We demonstrated with the MICA 
that the protein GAD is one of the autoantigens recog- 
nized by ICA and we suggest that proteins as well as gan- 
gliosides are potential candidates for additional target 
antigens of ICA beside GAD. 
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